Tuesday 26 November 2019

BioLargo Water Collaborator Presented Peer-Reviewed Abstract on AOS Micropollutant Treatment Results at Society of Environmental Toxicology and Chemistry (SETAC) International Conference


We have previously reported in press releases and other public disclosures about the special capabilities for BioLargo’s Advanced Oxidation System (AOS) clean water technology to eliminate micropollutants from water.

Recently, Yuhe He from the lab of Dr. Greg Goss at the University of Alberta presented his work on this topic at the Society of Environmental Toxicology and Chemistry (SETAC) North America Annual Meeting in Toronto, Ontario. The study he presented focused on demonstrating that the AOS is effective in reducing the toxicity of micropollutant-contaminated municipal wastewater. You can read more about his work below.

Micropollutants are widespread and persistent contaminants of significant concern to regulators due to environmental and human health concerns and are difficult to treat using conventional wastewater treatment technologies (such as UV and biological treatment). The fact that our AOS technology shows significant promise as a solution to address micropollutant contamination in municipal water creates a significant opportunity for BioLargo Water to solve a substantial and widespread market need.

BioLargo Water and its collaborators are also committed to disseminating their scientific findings (on the AOS or otherwise) at internationally recognized peer-reviewed scientific meetings such as this one, as part of our mission to advance the understanding and science of water treatment.

Municipal wastewater outflow




















The abstract for the presentation delivered by Mr. He is available here:


Assessment on the Environmental Safety of Advanced Oxidation Water Treatment System (AOS)
Y. He, City University of Hong Kong / School of Energy and Environment;
G. Goss, University of Alberta / Biological Sciences;
L. Patterson-Fortin, R. Smith, BioLargo Water, Inc.

The Advanced Oxidation System (AOS) is a water treatment technology for bacterial disinfection and contamination remediation. The AOS can effectively remove bacterial and organic contaminants from water through the electrochemical manipulation of potassium iodide salt, electrolysis, and expanded graphite adsorption. Iodine acts as the primary disinfectant in the system. Evidence shows formation of additional iodinated and oxidative species, which may contribute to the disinfection and decontamination achieved by the AOS reactor. However, the formation of reactive oxygen species and potential secondary oxidative species may pose additional hazards to aquatic organism living in the receiving water affected by the post-treatment effluent. The effect of exposure to AOS treated waters, especially the long-term effect on aquatic ecosystem receptors (fish, invertebrates) is a commonly raised subject of concern, and thus requires further investigation to demonstrate both efficacy and safety of this process. To examine the long-term effects of AOS treated water, a 21-day chronic daphnia exposure, a 96-hour acute zebrafish embryo exposure, and a 14-day chronic rainbow trout exposure, were conducted, with treated and untreated municipal wastewater effluent (MWE) spiked with model organic contaminants, benzo[a]pyrene and 17╬▓-estradiol. The results indicated AOS treatment significantly reduced the adverse effects caused by exposure to MWE and model organic contaminants to baseline levels in daphnia (reduced fecundity), zebrafish embryo (elevated EROD activity), and rainbow trout (elevated plasma vitellogenin). Overall, this study demonstrated that AOS treatment is a promising and environmentally friendly technology for wastewater treatment

Thursday 21 November 2019

CEORoadshow Interview with Dennis Calvert, President & CEO of BioLargo, Inc. - Highlights Record Quarter and PFAS Solution

Source: CEORoadshow


In this episode of CEO Roadshow we are joined by Mr. Dennis Calvert, President & CEO of BioLargo, Inc., developer of sustainable technologies and a full-service environmental engineering company.
They trade under the ticker BLGO.

Wednesday 13 November 2019

BioLargo CEO Interviewed at The Wall Street Resource



Westminster, CA, Nov. 13, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioLargo (OTCQB: BLGO), developer of sustainable technologies and full-service environmental engineering, announced today that its President & CEO Dennis P. Calvert was interviewed by The Wall Street Resource, a platform for microcap company news and due diligence. The interview can be accessed here: https://thewallstreetresource.com/webcasts/.

Mr. Calvert’s interview highlighted several of BioLargo’s innovative clean tech products and services. In particular, Mr. Calvert gave an update on the development of the company’s new water treatment technology designed to address per- and poly-fluoroalkyl substances (PFAS), a class of water contaminants of growing concern in the US.

The interview with Mr. Calvert was published at 2:00 p.m. PST on November 13, 2019.  The interview webcast is free of cost to all listeners and available at www.thewallstreetresource.com. In addition, the interview will be available for replay.

About Biolargo (BLGO) 
BioLargo invents, patents, and develops innovative platform technologies for three markets: 1) advanced water and wastewater treatment, 2) industrial odor and VOC control, and 3) advanced wound care products. With a wide array of issued patents, an extensive R&D talent pool, and a full-service engineering team, the company maintains a robust pipeline of products from inception through maturity.  BioLargo monetizes its technology assets with the goal of maximizing both impact and shareholder value, using licensing, strategic partnership, and direct-to-market strategies. 

About The Wall Street Resource
The Wall Street Resource.com is a platform for microcap discovery and due diligence. It's your resource for webcast interviews of CEOs and executives. For more information, please visit: www.thewallstreetresource.com

Safe Harbor Act
This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

Contact Information
Dennis P. Calvert, President & CEO of BioLargo, Inc. 
888-400-2863

Tuesday 12 November 2019

BioLargo, Inc. Updates the Stock Day Podcast on Quarterly Growth, Commercialization, and Its Role in Solving the PFAS Crisis

Source: Newsfile Corp.



Phoenix, Arizona--(Newsfile Corp. - November 12, 2019) - The Stock Day Podcast welcomed BioLargo, Inc. (OTCQB: BLGO), an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. President & CEO BioLargo, Dennis P. Calvert, joined Stock Day host Jamie Fellows.
Fellows began the interview by asking Mr. Calvert for an update on BioLargo's revenue growth and balance sheet. Calvert explained that the company will be publishing their quarterly report in just a few days. "The revenues for the quarter will come in at just about $500,000, which is another record for the company."
Calvert then expanded on BioLargo's progress in improving its balance sheet. "Just a few months ago, we were able to restructure short-term debt into long-term debt," explained Calvert. "We were also able to pay off and retire about $1.2 million in what the industry refers to as variable-priced debt. That's a big deal," said Calvert. He further explained that the company has followed an aggressive investment strategy, which is now paying off. "All of the fruits of these investments are now panning out," said Calvert. "I think it's a very exciting time for the company."
Fellows asked Mr. Calvert about the EPA grant that BioLargo Engineering was recently awarded to help solve the growing issue of PFAS (per- and poly-fluoroalkyl substances) contamination. Calvert explained that PFAS water contamination is a widespread problem because these chemicals are found in a vast number of household and industrial products and don't break down easily in nature. They are also linked to adverse health effects. "As a result, there is a big crisis," said Calvert. "People are finding that our groundwater is contaminated with PFAS," said Calvert.
Mr. Calvert then commented on the technology they developed as a result of the US EPA grant they were awarded. "We have proven claims that we're getting at least 99% reduction [from water] in a single pass," explained Calvert. "We're busy with patents, we're busy with scale-ups, and we're in discussion with major partnerships," said Calvert. "We've got the talent in-house to support this technology."
Mr. Calvert also answered questions about BioLargo's wound care subsidiary, Clyra Medical Technologies. "Clyra Medical just got its first FDA clearance, just a few weeks ago, for its first advanced wound care product," shared Calvert. "With that product, we can continue to focus on extraordinarily high-value assets," he continued. "Now what we're focused on is building that infrastructure, getting clinical [trials], and slowly entering the market," said Calvert.
Mr. Calvert closed the interview by saying, "We think the future for BioLargo is exceptionally exciting and it's a great time to take a look at this company."
Investors Hangout is a proud sponsor of "Stock Day," and Stock Day Media encourages listeners to visit the company's message board at https://investorshangout.com/
About BioLargo, Inc.
BioLargo, Inc. is an innovative technology developer and environmental engineering company driven by a mission to "make life better" by delivering robust, sustainable solutions for a broad range of industries and applications, with a focus on clean water, clean air, and advanced wound care. We develop and commercialize disruptive technologies by providing the capital, support, and expertise to expedite them from "cradle" to "maturity" (www.biolargo.com). Our engineering division features experienced professional engineers dedicated to integrity, reliability, and environmental stewardship (www.biolargoengineering.com). Our industrial odor control division, Odor-No-More (www.odornomore.com) features CupriDyne Clean Industrial Odor Eliminator (www.cupridyne.com), which eliminates the odor-causing compounds and VOCs rather than masking them, and is now winning over leading companies in the solid waste handling and wastewater industries and other industries that contend with malodors and VOCs. Our subsidiary BioLargo Water (www.biolargowater.ca) develops the Advanced Oxidation System "AOS," a disruptive industrial water treatment technology designed to eliminate waterborne pathogens and recalcitrant contaminants with better energy-efficiency and lower operational costs than incumbent technologies. Our subsidiary Clyra Medical (www.clyramedical.com) features effective and gentle solutions for chronic infected wounds to promote infection control and regenerative tissue therapy.
Contact Information
Dennis P. Calvert
President & CEO, BioLargo, Inc.
888-400-2863
Safe Harbor Act
This press release includes "forward-looking statements" within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as "expect," "estimate," "project," "budget," "forecast," "anticipate," "intend," "plan," "may," "will," "could," "should," "believes," "predicts," "potential," "continue," and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.
About The "Stock Day" Podcast
Founded in 2013, Stock Day is the fastest growing media outlet for Nano-Cap and Micro-Cap companies. It educates investors while simultaneously working with penny stock and OTC companies, providing transparency and clarification of under-valued, under-sold Micro-Cap stocks of the market. Stock Day provides companies with customized solutions to their news distribution in both national and international media outlets. The Stock Day Podcast is the number one radio show of its kind in America. Stock Day recently launched its Video Interview Studio located in Phoenix, Arizona.
SOURCE:
Stock Day Media
602-441-3474